These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37132279)

  • 1. Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.
    Rudilosso S; Stringer MS; Thrippleton M; Chappell F; Blair GW; Jaime Garcia D; Doubal F; Hamilton I; Janssen E; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; Duering M; Dichgans M; Wardlaw JM;
    J Cereb Blood Flow Metab; 2023 Sep; 43(9):1490-1502. PubMed ID: 37132279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracer kinetic assessment of blood-brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors.
    Stringer MS; Heye AK; Armitage PA; Chappell F; Valdés Hernández MDC; Makin SDJ; Sakka E; Thrippleton MJ; Wardlaw JM
    Neuroimage Clin; 2021; 32():102883. PubMed ID: 34911189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of acute infarcts to cerebral small vessel disease progression.
    Ter Telgte A; Wiegertjes K; Gesierich B; Marques JP; Huebner M; de Klerk JJ; Schreuder FHBM; Araque Caballero MA; Kuijf HJ; Norris DG; Klijn CJM; Dichgans M; Tuladhar AM; Duering M; de Leeuw FE
    Ann Neurol; 2019 Oct; 86(4):582-592. PubMed ID: 31340067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
    Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
    Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
    Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
    J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A typology of cerebral small vessel disease based on imaging markers.
    Sperber C; Hakim A; Gallucci L; Seiffge D; Rezny-Kasprzak B; Jäger E; Meinel T; Wiest R; Fischer U; Arnold M; Umarova R
    J Neurol; 2023 Oct; 270(10):4985-4994. PubMed ID: 37368130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants and Temporal Dynamics of Cerebral Small Vessel Disease: 14-Year Follow-Up.
    Cai M; Jacob MA; van Loenen MR; Bergkamp M; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Sep; 53(9):2789-2798. PubMed ID: 35506383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease.
    Rudilosso S; Chui E; Stringer MS; Thrippleton M; Chappell F; Blair GW; Garcia DJ; Doubal F; Hamilton I; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; van Oostenbrugge R; Duering M; Dichgans M; Wardlaw JM;
    Neurology; 2022 Aug; 99(5):e440-e452. PubMed ID: 35606147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study.
    Sleight E; Stringer MS; Clancy U; Arteaga C; Jaime Garcia D; Hewins W; Jochems ACC; Hamilton OKL; Manning C; Morgan AG; Locherty R; Cheng Y; Liu X; Zhang J; Hamilton I; Jardine C; Brown R; Sakka E; Kampaite A; Wiseman S; Valdés-Hernández MC; Chappell FM; Doubal FN; Marshall I; Thrippleton MJ; Wardlaw JM
    Stroke; 2023 Nov; 54(11):2776-2784. PubMed ID: 37814956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative MRI evaluation of cerebral small vessel disease in an elderly population: a longitudinal study.
    Nylander R; Fahlström M; Rostrup E; Kullberg J; Damangir S; Ahlström H; Lind L; Larsson EM
    Acta Radiol; 2018 May; 59(5):612-618. PubMed ID: 28814098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the clinical feasibility of detecting subtle blood-brain barrier leakage in cerebral small vessel disease using dynamic susceptibility contrast MRI.
    Elschot EP; Backes WH; de Jong JJA; Drenthen GS; Wong SM; Staals J; Postma AA; Rouhl RPW; van Oostenbrugge RJ; Jansen JFA
    Magn Reson Imaging; 2023 Oct; 102():55-61. PubMed ID: 37137345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.
    Pasi M; Boulouis G; Fotiadis P; Auriel E; Charidimou A; Haley K; Ayres A; Schwab KM; Goldstein JN; Rosand J; Viswanathan A; Pantoni L; Greenberg SM; Gurol ME
    Neurology; 2017 Jun; 88(23):2162-2168. PubMed ID: 28476760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities associated with progression of cerebral small vessel disease: a 7-year Chinese urban community study.
    Xia Y; Shen Y; Wang Y; Yang L; Wang Y; Li Y; Liang X; Zhao Q; Wu J; Chu S; Liang Z; Wang X; Qiu B; Ding H; Ding D; Cheng X; Dong Q
    Aging (Albany NY); 2020 May; 12(9):8506-8522. PubMed ID: 32388497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
    Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
    Front Immunol; 2021; 12():803504. PubMed ID: 34956241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
    Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
    Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Walsh J; Tozer DJ; Sari H; Hong YT; Drazyk A; Williams G; Shah NJ; O'Brien JT; Aigbirhio FI; Rosenberg G; Fryer TD; Markus HS
    Brain; 2021 Jun; 144(5):1361-1371. PubMed ID: 34000009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier leakage at baseline and cognitive decline in cerebral small vessel disease: a 2-year follow-up study.
    Kerkhofs D; Wong SM; Zhang E; Uiterwijk R; Hoff EI; Jansen JFA; Staals J; Backes WH; van Oostenbrugge RJ
    Geroscience; 2021 Aug; 43(4):1643-1652. PubMed ID: 34160780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Small Vessel Disease and Financial Capacity: A Study Based on Cognitively Normal Older Adults.
    Luo X; Hong H; Li K; Zeng Q; Liu X; Hong L; Li J; Zhang X; Zhong S; Xu X; Chen Y; Zhang M; Huang P;
    J Alzheimers Dis; 2024; 98(3):897-906. PubMed ID: 38461505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.